{
    "symbol": "NTNX",
    "quarter": 1,
    "year": 2022,
    "date": "2021-11-23 20:12:03",
    "content": " ACV billings to be between $195 million and $200 million, representing year-over-year growth of 23% to 26%; revenue of $400 million to $410 million; gross margin of approximately 82% to 82.5%; operating expenses between $360 million and $365 million; and weighted average shares outstanding of approximately $218 million. ACV billings to be between $740 million and $750 million, representing year-over-year growth of 25% to 26%; revenue of $1.615 billion to $1.630 billion; gross margin of approximately 82%; and operating expenses between $1.48 billion to $1.49 billion."
}